Loading organizations...
Developing disease-modifying treatments for age-related diseases.
Underdog Pharmaceuticals has raised $10.0M across 1 funding round.
Underdog Pharmaceuticals has raised $10.0M in total across 1 funding round.
Underdog Pharmaceuticals has raised $10.0M in total across 1 funding round.
Underdog Pharmaceuticals's investors include Frank Schueler.
Underdog Pharmaceuticals has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Seed in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 23, 2021 | $10.0M Seed | Frank Schueler |